Summary information

Study title

International Study of Asthma and Allergies in Childhood, 1992-2005

Creator

Strachan, D., University of London
Pearce, N., London School of Hygiene and Tropical Medicine, Department of Medical Statistics
Garcia-Marcos, L., University of Murcia (Spain), Department of Paediatrics
Asher, I., University of Auckland, Department of Paediatrics, Child and Youth Health

Study number / PID

8131 (UKDA)

10.5255/UKDA-SN-8131-1 (DOI)

Data access

Open

Series

Not available

Abstract

Abstract copyright UK Data Service and data collection copyright owner.The International Study of Asthma and Allergies in Childhood (ISAAC) was a worldwide epidemiological research programme established in 1991 to investigate asthma, rhinoconjunctivitis and eczema in children, due to considerable concern that these conditions were increasing in many countries, and that the causes of this increase were unknown. ISAAC Phase One was an international multi-centre cross-sectional study involving two age groups of school children, 13-14 year olds (adolescents) and 6-7 year olds (children). Schools were randomly selected from a defined geographical area. Written questionnaires on asthma, rhinitis and eczema symptoms (translated from English) were completed by the adolescents at school, and at home by the parents of the children. An asthma symptoms video questionnaire for the adolescents was optional. ISAAC Phase Two involved more intensive studies in a smaller number of selected centres. Children aged 8-12 years were examined for flexural dermatitis, underwent skin prick tests for atopy, bronchial responsiveness to hypertonic saline, blood sampling and storage for serum IgE and genetic analyses, and additional questionnaires were completed by their parents. ISAAC Phase Three, a repeat of Phase One after at least five years, examined variations in time trends of childhood asthma, rhinoconjunctivitis and eczema around the world, and expanded the world maps of these conditions. Additional questions on risk factors were included in Phase Three. The ISAAC programme grew to involve nearly 2 million children from 306 study centres in 105 countries, before it formally closed in December 2012. Further information about the study can be found on the ISAAC study website.Main Topics:Prevalence and severity of symptoms of asthma, rhinoconjunctivitis and eczema in schoolchildren. Individual risk factors for these conditions. Trends over time in prevalence of these conditions.
Read more

Methodology

Data collection period

01/06/1992 - 01/03/2005

Country

Multi-nation

Time dimension

Repeated cross-sectional study
Not all centres took part in both Phase One and Phase Three, so information is available on a one-time basis from some centres and a repeated cross-sectional basis from others. Some centres undertook Phase Two in the same study area as Phase One (but in a different age group). Other centres in Phase Two are not represented in either Phase One or Phase Three.

Analysis unit

Individuals
Cross-national
National

Universe

Almost 2 million children aged 6-7 or 13-14 years from about 300 study centres in over 100 countries took part in either ISAAC Phase One or ISAAC Phase Three (questionnaire surveys). Over 50,000 children aged 8-12 years from 30 study centres in 23 countries took part in ISAAC Phase Two, which involved clinical tests for asthma and allergy as well as data collection by questionnaire.

Sampling procedure

One-stage stratified or systematic random sample
In Phase Two, some measurements in some centres were performed only on a stratified sample, with two strata: wheezy children and non-wheezy children.

Kind of data

Numeric

Data collection mode

Postal survey
Self-completion
Clinical measurements
Self-completion (at school) used for 13-14-year-olds. Postal questionnaire (distributed to parents via schools) used for younger age-groups. Clinical measurements restricted to Phase Two only.

Access

Publisher

UK Data Service

Publication year

2017

Terms of data access

  The Data Collection is to be made available to any user without the requirement for registration for download/access under a Creative Commons Attribution 4.0 International Licence.

Related publications

Not available